Cite
HARVARD Citation
Bantel, H. et al. (2017). Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply. Alimentary pharmacology & therapeutics. 45 (1), pp. 184-185. [Online].